RxDoctor Payments Data

Diana Bannister

Acute Care · Dallas, TXNPI 1417228727

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 127 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by AbbVie at 34.4% of the total. Reporting peaked in 2021 at $1,502 and has fallen 99.1% since, to $14 in 2025.

$1,945in general payments, 2019–2025

Across 127 payments — averaging $15.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$668
  • Sunovion Pharmaceuticals Inc.$345
  • SK Life Science, Inc.$209
  • Eisai Inc.$182
  • Genentech USA, Inc.$102
  • Amgen$97
  • plus $342 from 12 others

What the payments were for

  • Food & beverage$1,945100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,945 in reported general payments places this provider in the 80th percentile of 2,323 acute care providers in Texas.

See all acute care providers in Texas →

Other acute care in Dallas

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →